February 03, 2011
Fera announced that Puralube (white petrolatum and mineral oil), a preservative free ophthalmic ointment, is available again to relieve the symptoms of dry eye.
December 23, 2010
RegeneRx Biopharmaceuticals announced that the first patient has been screened and is being enrolled in a Phase 2 clinical trial testing the Company's drug candidate RGN-259 in patients with dry eye associated with graft vs. host disease.
October 12, 2010
Alcon announced that it has expanded its Systane product line with the launch of Systane Balance lubricant eye drops for evaporative dry eye in patients with Meibomian Gland Dysfunction (MGD).
September 28, 2010
ISTA Pharmaceuticals announced the results from its Phase 2 trial of Remura (bromfenac ophthalmic solution) for the treatment of dry eye disease.
May 11, 2010
The FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) has launched the Bad Ad Program, designed to educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful, and not misleading.